 | | | | Medical Health Encyclopedia | |
Neonatal cystic fibrosis screening
| | | |
| |
| |
| Neonatal cystic fibrosis screening |
|
Definition:
Neonatal cystic fibrosis screening is a blood test that looks for increased levels of immunoreactive trypsinogen (IRT), an enzyme produced by the pancreas. The test is performed on newborns to diagnose cystic fibrosis (CF). Alternative Names:
Cystic fibrosis screening - neonatal; Immunoreactive trypsinogen; IRT test Text Continues Below
How the test is performed:
A sample of blood is either taken from the bottom of the baby's foot of a vein in the arm. A tiny drop of blood is collected onto a piece of filter paper and allowed to dry. The dried blood sample is sent to a lab for analysis. How to prepare for the test:
Your health care provider will explain the test to you, and you must sign a consent form before the test. Some states, but not all, include this test in the newborn screening exams that are done before the mother and baby leave the hospital. How the test will feel:
The brief feeling of discomfort will probably cause your baby to cry. Why the test is performed:
Infants who have CF may have increased levels of IRT in their blood for several months after birth. A positive IRT test requires follow up testing to confirm the diagnosis. References:
Gross, SD, Boyle, CA, Botkin, JR, et al. Newborn Screening for Cystic Fibrosis:Evaluation of Benefits and Risks and Recommendations for State Newborn Screening Programs. MMWR. 2004;53(RR13);1-36.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2004 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
| |
| 
.gif)
